The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein

References

• Ostrom QT, Cote DJ, Ascha M, et al. Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol. 2018;4(9):1254–1262.
   PubMed Web of Science ®Google Scholar
• Lu VM, Goyal A, Quinones-Hinojosa A, et al. Updated incidence of neurological deficits following insular glioma resection: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2019;177:20–26.
   PubMed Web of Science ®Google Scholar
• Fayzullin A, Sandberg CJ, Spreadbury M, et al. Phenotypic and expressional heterogeneity in the invasive glioma cells. Transl Oncol. 2019;12(1):122–133.
   PubMed Web of Science ®Google Scholar
• Clarke MF. Clinical and therapeutic implications of cancer stem cells. N Engl J Med. 2019;380(23):2237–2245.
   PubMed Web of Science ®Google Scholar
• Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23(10):1124–1134.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li X, Wang T, et al. Emerging agents that target signaling pathways in cancer stem cells. J Hematol Oncol. 2020;13(1):60.
   PubMed Web of Science ®Google Scholar
• van Well EM, Bader V, Patra M, et al. A protein quality control pathway regulated by linear ubiquitination. EMBO J. 2019;38:9.
   Web of Science ®Google Scholar
• Faktor J, Pjechova M, Hernychova L, et al. Protein ubiquitination research in oncology. Klin Onkol. 2019;32(Suppl 3):56–64.
   PubMedGoogle Scholar
• Wiener R, Zhang X, Wang T, et al. The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature. 2012;483(7391):618–622.
   PubMed Web of Science ®Google Scholar
• Karunarathna U, Kongsema M, Zona S, et al. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance. Oncogene. 2016;35(11):1433–1444.
   PubMed Web of Science ®Google Scholar
• Baietti MF, Simicek M, Abbasi Asbagh L, et al. OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination. EMBO Mol Med. 2016;8(3):288–303.
   PubMed Web of Science ®Google Scholar
• Xu L, Li J, Bao Z, et al. Silencing of OTUB1 inhibits migration of human glioma cells in vitro. Neuropathology. 2017;37(3):217–226.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun XX, Elferich J, et al. Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein. J Biol Chem. 2014;289(8):5097–5108.
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang Y, Ling J, et al. Overexpression of SLC7A11: a novel oncogene and an indicator of unfavorable prognosis for liver carcinoma. Future Oncol. 2018;14(10):927–936.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Sorensen MF, Heimisdottir SB, Sorensen MD, et al. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma. J Neurooncol. 2018;138(1):49–53.
   PubMed Web of Science ®Google Scholar
• Robert SM, Buckingham SC, Campbell SL, et al. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci Transl Med. 2015;7(289):289ra286.
   Web of Science ®Google Scholar
• Polewski MD, Reveron-Thornton RF, Cherryholmes GA, et al. SLC7A11 overexpression in glioblastoma is associated with increased cancer stem cell-like properties. Stem Cells Dev. 2017;26(17):1236–1246.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang X, Wei C, et al. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Eur J Pharm Sci. 2020;152:105450.
   PubMed Web of Science ®Google Scholar
• Shin VY, Chen J, Cheuk IW, et al. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness. Cell Death Dis. 2019;10(4):270.
   PubMedGoogle Scholar
• Ju HQ, Lu YX, Chen DL, et al. Redox regulation of stem-like cells though the CD44v-xCT axis in colorectal cancer: mechanisms and therapeutic implications. Theranostics. 2016;6(8):1160–1175.
   PubMed Web of Science ®Google Scholar
• Yue W, Hamai A, Tonelli G, et al. Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance. Autophagy. 2013;9(5):714–729.
   PubMed Web of Science ®Google Scholar
• Mai TT, Hamai A, Hienzsch A, et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat Chem. 2017;9(10):1025–1033.
   PubMed Web of Science ®Google Scholar
• White RA, Neiman JM, Reddi A, et al. Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest. 2013;123(10):4390–4404.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu W, Liu F, et al. IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR pathway in colorectal cancer. Oxid Med Cell Longev. 2020;2020:1675613.
   PubMed Web of Science ®Google Scholar
• Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34.
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Wilkey CJ, Phan TTN. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes. J Biol Chem. 2019;294(28):10928–10941.
   PubMed Web of Science ®Google Scholar
• Wu J, Minikes AM, Gao M, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019;572(7769):402–406.
   PubMed Web of Science ®Google Scholar
• Morotti M, Bridges E, Valli A, et al. Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. Proc Natl Acad Sci U S A. 2019;116(25):12452–12461.
   PubMed Web of Science ®Google Scholar
• Durusu IZ, Husnugil HH, Atas H, et al. Anti-cancer effect of clofazimine as a single agent and in combination with cisplatin on U266 multiple myeloma cell line. Leuk Res. 2017;55:33–40.
   PubMed Web of Science ®Google Scholar
• Sun T, Xu Y, Xu Z, et al. Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis. Cell Commun Signal. 2021;19(1):24.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xu M, Tong J, et al. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma. Blood. 2021;137(11):1478–1490.
   PubMed Web of Science ®Google Scholar
• Xu Y, Sun T, Zeng K, et al. Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf. Cell Death Dis. 2020;11(9):818.
   PubMed Web of Science ®Google Scholar